Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for treatment of COVID-19
IRCT20200509047364N3Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in coronavirus disease 2019 (COVID-19), sponsored by Hormozgan University of Medical Sciences. Started Mar 2021; status: completed.
02
Drugs
acetylcysteine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200509047364N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200509047364N3.